| Navn |
Titel |
| Helle Brøndsted |
MSc (pharm), PhD, Product Specialist, DGM Denmark A/S |
| Troels V. Christensen |
MSc (eng.), Senior Product Life Cycle Manager, H. Lundbeck A/S |
| Gitte Dyhr |
MSc (pharm), Associate Senior Director, Head of Labelling Committee, Regulatory Affairs, H. Lundbeck A/S |
| Jan Fleckner |
Ph.D., Director, Translational Science, Biomarker Expert, Novo Nordisk A/S |
| Annette Byrholt Hansen |
MSc (Pharmacy), PhD, Head of Department, Inspection Laboratory and Inspection Division, Danish Medicines Agency |
| Jesper Kihl |
MSc (Chem. Eng.), Executive Master (coaching and consulting for change), Senior Advisor, Regulatory Affairs, Keiken Aps |
| Frank Larsen |
MSc (pharmacy), PhD, Chief Specialist, Clinical & Quantitative Pharmacology, H. Lundbeck A/S |
| Katarina Jelic Maiboe |
MSc (Pharm), PhD, Vice President Regulatory Affairs, HMNC Brain Health |
| Morten Munk |
BSc Hon (Chem. Eng), Engineering Technology Management (ETM), Director, Alliance Management, FUJIFILM Diosynth Biotechnologies |
| Alejandra Mørk |
MSc (Pharmacy), PhD, Managing Director, Klifo A/S |
| Helle Northeved |
DVM, PhD, Senior Vice President, Nonclinical Safety Research, H. Lundbeck A/S |
| Jane Møll Pedersen |
Vice President RA Biopharm 2, Novo Nordisk A/S |
| Morten Just Petersen |
MSc (chemistry), Master of Industrial Drug Development, Chief Development Officer, MonTa Biosciences |
| Kresten Skak |
MSc (Biochemistry); PhD (Immunology), Senior Director, Immunopharmacology, Dragonfly Therapeutics |
| Steffen Thirstrup |
MD, PhD (pharmacology), Chief Medical Officer, The European Medicines Agency, Amsterdam, Netherlands |
